Loading clinical trials...
Loading clinical trials...
Double-Blind, Placebo-Controlled Study of Pyridostigmine in Postural Tachycardia Syndrome
Conditions
Interventions
pyridostigmine
Placebo
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
October 1, 2006
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2027
Last Updated
March 5, 2026
NCT07189936
NCT05421208
NCT04271878
NCT00692471
NCT04140721
NCT05409651
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions